Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glasdegib vs Placebo in Myelofibrosis
NCT02226172Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Oct 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of glasdegib in myelofibrosis (MF), sponsored by Pfizer. Started Oct 2014; status: terminated.
02
Drugs
glasdegib
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT02226172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02226172.